|
4. Dépistage, diagnostic et pronostic
|
|
|
Can Craig Venter Cheat Death? [Forbes]
|
|
|
|
|
|
Venter
believes the problem with earlier screening tests is that they give too
little data, not too much. He is his own evidence. He was the first
person to get his DNA sequenced, and the results made him think his risk
for most types of cancer was low. When he got prostate cancer, he asked
his researchers why. They found what he calls "the likely perpetrator."
|
|
|
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
|
4.10 Dép., diag. & prono. - Poumon
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.2 Pharma
|
|
|
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.4 Traitements - Economie
|
|
|
NICE draft guidelines reject Ipsen’s Cabometyx [PharmaTimes]
|
|
|
|
|
|
NICE's
independent appraisal committee concluded that the additional benefits
of the drug, when compared with current care, "were highly uncertain as
the meta-analysis evidence presented by the company was unreliable," a
NICE spokesperson said.
|
|
|
|
|
|
|
5.5.4 ASCO (immunothérapies)
|
|
|
|
Response to Cancer Immunotherapy May Depend on Gut Bacteria [ASCO]
|
|
|
|
|
|
In
the study, the ability of patients with advanced melanoma to respond to
PD-1 immune checkpoint inhibitors depended on the presence of a diverse
microbiome as well as specific bacterial species. The study will be
presented at the upcoming 2017 ASCO-SITC Clinical Immuno-Oncology
Symposium in Orlando.
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
|
|
6.10 Politiques
|
|
|
China biotech makes big data a weapon in its war on cancer [China Daily]
|
|
|
|
|
|
China
has made the precision medicine field a focus of its 13th Five-Year
Plan (2016-20), and its companies have been embarking on ambitious
efforts to collect a vast trove of genetic and health data, researching
how to identify cancer markers in blood, and launching consumer
technologies that aim to tap potentially lifesaving information.
|
|
|
|
|
6.11 Patients
|
|
|
|
|
6.6 Publications
|
|
|
No publication without confirmation [Nature]
|
|
|
|
|
|
Our
proposal is a new type of paper for animal studies of disease therapies
or preventions: one that incorporates an independent, statistically
rigorous confirmation of a researcher's central hypothesis.
|
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|